Loading...

WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease

Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM-5 also states proxy measures may be useful when c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Hum Genet
Main Authors: Downing, Nancy R, Kim, Ji-In, Williams, Janet K, Long, Jeffrey D, Mills, James A, Paulsen, Jane S
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350592/
https://ncbi.nlm.nih.gov/pubmed/24327189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.275
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!